These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32099349)

  • 1. Erratum: Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2020; 15():247-248. PubMed ID: 32099349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between N-terminal probrainnatriuretic peptide and prognosis of acute exacerbations of chronic obstructive pulmonary disease].
    Zhao CL; Zhang QR; Huang JW; Zhang L; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):95-99. PubMed ID: 29429214
    [No Abstract]   [Full Text] [Related]  

  • 4. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():853. PubMed ID: 33824585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [NT-proBNP in chronic obstructive pulmonary disease patients].
    Sánchez-Marteles M; Cecilio-Irazola A; Vañó-Sanchis D; Nuviala-Mateo R; Serrano-Martínez S; Pérez-Calvo JJ
    An Sist Sanit Navar; 2009; 32(2):235-41. PubMed ID: 19738647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic role of extremely high levels of the B-type natriuretic prohormone with regard to the in-hospital mortality of patients hospitalized for heart failure].
    Bózsik B; Nagy E; Somlói M; Tomcsányi J
    Orv Hetil; 2017 May; 158(20):779-782. PubMed ID: 28502208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Effects of Ambient Temperature on Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results from a Time-Series Analysis of 143318 Hospitalizations [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2129-2131. PubMed ID: 34321873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum].
    J Inflamm Res; 2022; 15():1993-1994. PubMed ID: 35360450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E; Chang CL; Cooray M; Tuffery CM; Hopping SJ; Sullivan GD; Jacobson GA; Hancox RJ
    Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2017; 12():229. PubMed ID: 28138231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
    Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
    Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.
    Behnes M; Brueckmann M; Lang S; Espeter F; Weiss C; Neumaier M; Ahmad-Nejad P; Borggrefe M; Hoffmann U
    Eur J Heart Fail; 2013 Dec; 15(12):1390-400. PubMed ID: 23851388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2019; 14():mmclxxiii. PubMed ID: 31571854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Predicting frequent COPD exacerbations using primary care data [Corrigendum].
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2471. PubMed ID: 30147313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of NT-proBNP serum level in the diagnosis of dyspnea in COPD patients].
    Rubinsztajn R; Nasiłowski J; Przybyłowski T; Karwat K; Chazan R
    Pneumonol Alergol Pol; 2013; 81(1):24-9. PubMed ID: 23258468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.
    Jaberg L; Toggweiler S; Puck M; Frank M; Rufibach K; Lüscher TF; Corti R
    Circ J; 2011; 75(11):2648-53. PubMed ID: 21891968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.